Skin Neoplasms
37
1
3
22
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.5%
5 terminated out of 37 trials
81.5%
-5.0% vs benchmark
14%
5 trials in Phase 3/4
27%
6 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (37)
M7824 Related Adverse Effects in Adults With Cancer
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery
A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
Spanish Registry of Mohs Surgery
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
I am Protecting my Child From the Sun Program
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Imatinib Mesylate in Treating Patients With Metastatic Melanoma